Katherine A Davies
6PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 26, 2023
Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization.Yanxiang Meng, Sarah E Garnish, Katherine A Davies
|Apr 28, 2023
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.Catia L Pierotti, Annette V Jacobsen, Christoph Grohmann
|Mar 10, 2022
Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL.Ashish Sethi, Christopher R Horne, Cheree Fitzgibbon
|Nov 23, 2021
Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.Yanxiang Meng, Katherine A Davies, Cheree Fitzgibbon
|Jun 21, 2020
Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues.Katherine A Davies, Cheree Fitzgibbon, Samuel N Young
|Jun 21, 2020
MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis.Andre L Samson, Ying Zhang, Niall D Geoghegan
Pageof 1
Frequent Collaborators
6 joint publications
James M Murphy
4 joint publications
Joanne M Hildebrand
4 joint publications
Peter E Czabotar
3 joint publications
Andre L Samson
3 joint publications
Christopher R Horne
2 joint publications
Yanxiang Meng
2 joint publications
Annette V Jacobsen
2 joint publications
Guillaume Lessene
2 joint publications
Jarrod J Sandow
1 joint publications
Michael J Mlodzianoski
